Supplemental material
Expert Opinion on Biological Therapy
Volume 19, 2019 - Issue 7
Original Research
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
, , , , , , , 
, , , , , , , & show all
Rob C. RooversMerus N.V., Utrecht, The Netherlandshttps://orcid.org/0000-0002-9715-2136View further author information
https://orcid.org/0000-0002-9715-2136View further author information, , , , , , , Harry DolstraDepartment of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlandshttps://orcid.org/0000-0002-3998-687XView further author information
https://orcid.org/0000-0002-3998-687XView further author information & show allRelated Research Data
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
Source:
Figshare
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis
Source:
Figshare
Linking provided by
